• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    First Procedure Of Medigus Tech MUSE In Switzerland

    Bryan Mc Govern
    Mar. 14, 2017 09:39AM PST
    Medical Device Investing

    Medigus (NASDAQ:MDGS) announced the first procedures of its MUSE technology in Europe were performed successfully in treating patients with digestive diseases.

    Medigus (NASDAQ:MDGS) announced the first procedures of its MUSE technology in Europe were performed successfully in treating patients with digestive diseases.
    As quoted in the press release:

    The first MUSE procedures were performed in Switzerland by Prof. Dr. Gerhard Treiber at the Center for Digestive Diseases (Gastrozentrum) at Hirslanden Clinic in Aarau. It was reported that both procedures were successful and the patients were released from the hospital.
    “I believe that the MUSE procedure will be beneficial for many of my patients suffering from long-term treatment of GERD,” said Prof. Dr. Gerhard Treiber M.D./AGAF, Endoskopieabteilung (Endoscopy Unit), Center for Digestive Diseases (Gastrozentrum) at Hirslanden Clinic. “The procedures were efficient, and my patients were pleased with the incisionless approach, leading to potential reduced recovery time when compared to alternative options.”
    The MUSE system is a single-use flexible transoral stapler that merges the latest advancements in microvisual, ultrasonic and surgical stapling. The device comes equipped with an ultrasonic sight and range finder and a micro ScoutCam™ CMOS camera, which enables a single physician to perform an incisionless transoral fundoplication — the procedure intended to treat the anatomical cause of gastroesophageal reflux disease (GERD).
    “We are excited that MUSE is now being offered in Switzerland, expanding our availability in Europe,” said Chris Rowland, Chief Executive Officer of Medigus. “Our minimally invasive solution for gastroesophageal reflux disease (GERD) can help reduce the unmet treatment need for patients who fall within the gap between drug therapy and invasive surgical procedures.”
    To learn more about MUSE, visit: www.medigus.com
    About Medigus
    Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. They are the pioneer developer of the MUSE™ system, an FDA cleared and CE marked endoscopic device to perform Transoral Fundoplication (TF) for the treatment of GERD (gastroesophageal reflux disease), one of the most common chronic conditions in the world. In 2016, the CMS established the Category I CPT® Code of 43210 for TF procedures, such as the ones performed with MUSE, which establishes reimbursement values for physicians and hospitals. MUSE is gaining adoption in key markets around the world — it is available in world-leading healthcare institutions in the U.S., Europe and Israel. Medigus is also in the process of obtaining regulatory clearance in China. Medigus is traded on the Nasdaq Capital Market and the TASE (Tel-Aviv Stock Exchange). To learn more about the company’s advanced technology, please visit www.medigus.com or www.RefluxHelp.com.

    Click here to read the full press release.

    drug therapyeuropechinagastroesophageal reflux diseasemedical device companymedical device investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Stethoscope connected to a phone with medical data overlay.

    Top 5 Small-cap Medical Device Stocks (Updated January 2025)

    doctor with hands together, palms up below digital medical symbols

    Innovations and Opportunities in European Healthcare Technologies

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU

    Cleo Diagnostics

    COV:AU

    Ocumetics Technology

    OTC:CA

    Premier Health of America

    PHA:CA

    Bloom Health Partners

    BLMH:CNX

    Applied UV

    AUVI:NSD
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES